表紙:ブレインヘルスサプリメントの世界市場:市場規模 - 年齢層別、製品別、サプリメント形態別、用途別、販売チャネル別、地域別展望、競合戦略、セグメント別予測(~2032年)
市場調査レポート
商品コード
1170430

ブレインヘルスサプリメントの世界市場:市場規模 - 年齢層別、製品別、サプリメント形態別、用途別、販売チャネル別、地域別展望、競合戦略、セグメント別予測(~2032年)

Brain Health Supplements Market Size- By Age Group, By Product, By Supplement Form, By Application, By Sales Channel- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
ブレインヘルスサプリメントの世界市場:市場規模 - 年齢層別、製品別、サプリメント形態別、用途別、販売チャネル別、地域別展望、競合戦略、セグメント別予測(~2032年)
出版日: 2022年12月02日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のブレインヘルスサプリメントの市場規模は、2032年までに174億1,000万米ドルに達し、CAGRで8.53%の成長が予測されています。

人々の精神的、感情的な健康の低下により、COVID-19の流行は市場に好影響を与え、消費者の需要を増加させています。COVID-19の第二波により、消費者が重症呼吸器症候群から身を守るために日常生活で栄養補助食品を摂取するようになったため、ブレインヘルスサプリメントの需要が大幅に増加しました。

当レポートでは、世界のブレインヘルスサプリメント市場について調査し、市場力学、市場変数と展望、年齢層・製品・サプリメント形態・用途・販売チャネル・地域別の市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
  • 市場規模の推定
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 世界のブレインヘルスサプリメント市場におけるCOVID-19の影響

第5章 市場変数と展望

  • SWOT分析
    • 強み
    • 弱み
    • 機会
    • 脅威
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • 技術情勢
    • 環境情勢
    • 法的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競合企業間の敵対関係
  • ヒートマップ分析

第6章 世界のブレインヘルスサプリメント市場:年齢層別(2019年~2032年(100万米ドル))

  • 成人
  • 高齢者
  • 子供

第7章 世界のブレインヘルスサプリメント市場:製品別(2019年~2032年(100万米ドル))

  • ハーブエキス
    • バコパモニエリ
    • クルクミン
    • イチョウ
    • 高麗人参
    • ヤマブシタケ
    • その他
  • ビタミン・ミネラル
    • ビタミンB
    • ビタミンC・E
    • その他
  • 天然分子
    • アセチル-i-カルニチン
    • アルファgpc
    • シチコリン
    • ドコサヘキサエン酸
    • フペルジンA
    • その他

第8章 世界のブレインヘルスサプリメント市場:サプリメント形態別(2019年~2032年(100万米ドル))

  • カプセル
  • 錠剤
  • その他

第9章 世界のブレインヘルスサプリメント市場:用途別(2019年~2032年(100万米ドル))

  • 不安
  • 注意力・集中力
  • 長寿・アンチエイジング
  • 記憶力増強
  • 気分・うつ病
  • 睡眠・回復

第10章 世界のブレインヘルスサプリメント市場:販売チャネル別(2019年~2032年(100万米ドル))

  • 薬局
  • オンラインストア
  • スーパーマーケット・ハイパーマーケット
  • その他

第11章 世界のブレインヘルスサプリメント市場:地域別(2019年~2032年(100万米ドル))

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他の中東・アフリカ

第12章 企業プロファイル

  • Adisseo
    • 企業概要
    • 財務展望
    • 製品概要
    • 最近の開発
  • ADM
  • AlternaScript
  • BASF SE
  • BTSA Biotechnologias Aplicadas S.L.
  • DSM
  • Farbest Brands
  • Glanbia PLC
  • HVMN Inc.
  • Intelligent Labs
  • Lonza Group
  • Natural Factors Nutritional Product Ltd.
  • NOW Foods
  • Onnit Labs Inc.
  • Peak Nootropics
  • Purelife Bioscience Co. Ltd.
  • Rabar Pty Ltd.
  • Reckitt Benckiser Group PLC
  • SternVitamin GmbH & Co. KG
  • Teva Pharmaceutical Ltd.
目次
Product Code: PHAR2212

Global Brain Health Supplements Market Overview:

According to SPER Market Research, the Global Brain Health Supplements Market is estimated to reach USD 17.41 billion by 2032 with a CAGR of 8.53%.

Natural substances found in brain health supplements have advantageous impacts on the brain. These dietary supplements, which come in the form of herbal extracts in capsules, pills, and powders, assist healthy individuals in enhancing their memory, creativity, attention, motivation, and alertness. It has been demonstrated that herbs like withania somnifera and bacopa monniera enhance brain function. Additionally, B and C vitamins are good for the functioning of the nerves and brain. Supplements are goods that are utilised to correct and strengthen any kind of physical deficiencies in people. Supplements are available to consumers as tablets, capsules, soft gels, powders, or liquids. The type of supplements, such as herbal supplements and natural supplements, can be used to categorise them.

Impact of COVID-19 on the Global Brain Health Supplements Market:

Due to people's declining mental and emotional health, the COVID-19 epidemic has had a favorable effect on the market and increased consumer demand for these items. Due to the uncertainties surrounding the ongoing COVID-19 lawsuits around the world, people are spending more money on products that support memory. The epidemic has caused a disruption in the supply chain, affecting both the supply of finished goods and the acquisition of raw materials. The production of supplements has been somewhat impeded as a result of the bans that several nations have placed on the import and export of raw materials. The demand for brain health supplements has significantly increased as a result of the coronavirus 2nd wave, which has motivated consumers to consume dietary supplements in their everyday lives to protect themselves from severe respiratory syndrome coronavirus.

Scope of the Report:

Report Metric Details:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Age Group, By Product, By Supplement Form, By Application, By Sales Channel
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: Adisseo, ADM, AlternaScript, BASF SE, BTSA Biotechnologias Aplicadas S.L., DSM, Farbest Brands, Glanbia PLC, HVMN Inc., Intelligent Labs, Lonza Group, Natural Factors Nutritional Products Ltd., NOW Foods, Onnit Labs, Inc., Peak Nootropics, Purelife Bioscience Co., Ltd., Rabar Pty Ltd., Reckitt Benckiser Group PLC., SternVitamin GmbH & Co. KG, Teva Pharmaceutical Industries Ltd

Global Brain Health Supplements Market Segmentation:

  • By Age Group: Based on the Age Group, Global Brain Health Supplements Market is segmented as; Adults, Elderly and Kids.
  • By Product: Based on the Product, Global Brain Health Supplements Market is segmented as; Herbal Extracts (Bacopa monnieri, Curcumin, Ginkgo bilola, Ginseng, Lions mane, Others), Vitamins and Minerals (Vitamin B, Vitamin C & E, Others), Natural Molecules (Acetyle-i-carnitine, Alpha gpc, Citicoline, Docosahexaenoic acid, Huperzine A, others).
  • By Supplement Form: Based on the Supplement Form, Global Brain Health Supplements Market is segmented as; Capsules, Tablets and Others.
  • By Application: Based on the Application, Global Brain Health Supplements Market is segmented as; Anxiety, Attention and Focus, Longevity and Anti-aging, Memory Enhancement, Mood and Depression, Sleep and Recovery.
  • By Sales Channel: Based on the Sales Channel, Global Brain Health Supplements Market is segmented as; Drug Stores, Online Stores, Supermarkets and Hypermarkets and Others.
  • By Region: In recent years, North America has contributed the most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Adults in the United States regularly use nutritional supplements containing vitamins, minerals, and botanical components to boost their performance, energy, and mental clarity. These trends are probably going to accelerate the market expansion in the nation. According to the American Psychological Association, loneliness and uncertainty about the future are significant stressors for adolescents and young adults in America. As a result, it is anticipated that more and more adults will take supplements for brain health in order to maintain proper brain function.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Brain Health Supplements Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Brain Health Supplements Market, By Age Group, 2019-2032 (USD Million)

  • 6.1. Adults
  • 6.2. Elderly
  • 6.3. Kids

7. Global Brain Health Supplements Market, By Product, 2019-2032 (USD Million)

  • 7.1. Herbal Extracts
    • 7.1.1. Bacopa monnieri
    • 7.1.2. Curcumin
    • 7.1.3. Ginkgo bilola
    • 7.1.4. Ginseng
    • 7.1.5. Lions mane
    • 7.1.6. Others
  • 7.2. Vitamins and Minerals
    • 7.2.1 Vitamin B
    • 7.2.2 Vitamin C & E
    • 7.2.3 Others
  • 7.3. Natural Molecules
    • 7.3.1 Acetyle-i-carnitine
    • 7.3.2 Alpha gpc
    • 7.3.3 Citicoline
    • 7.3.4 Docosahexaenoic acid
    • 7.3.5 Huperzine A
    • 7.3.6 others

8. Global Brain Health Supplements Market, By Supplement Form, 2019-2032 (USD Million)

  • 8.1. Capsules
  • 8.2. Tablets
  • 8.3. Others

9. Global Brain Health Supplements Market, By Application, 2019-2032 (USD Million)

  • 9.1. Anxiety
  • 9.2. Attention and Focus
  • 9.3. Longevity and Anti-aging
  • 9.4. Memory Enhancement
  • 9.5. Mood and Depression
  • 9.6. Sleep and Recovery

10. Global Brain Health Supplements Market, By Sales Channel, 2019-2032 (USD Million)

  • 10.1 Drug Stores
  • 10.2 Online Stores
  • 10.3 Others
  • 10.4 Supermarkets and Hypermarkets

11. Global Brain Health Supplements Market, By Region, 2019-2032 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Adisseo
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 ADM
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 AlternaScript
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 BASF SE
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 BTSA Biotechnologias Aplicadas S.L.
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 DSM
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 Farbest Brands
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Glanbia PLC
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 HVMN Inc.
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 Intelligent Labs
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Lonza Group
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Natural Factors Nutritional Product Ltd.
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 NOW Foods
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 Onnit Labs Inc.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Peak Nootropics
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 Purelife Bioscience Co. Ltd.
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Rabar Pty Ltd.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Reckitt Benckiser Group PLC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 SternVitamin GmbH & Co. KG
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Teva Pharmaceutical Ltd.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments